A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

Clinical trial NCT07193589 · RECRUITING

Trial details

NCT number: NCT07193589
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2026-02-03
Primary completion: 2027-12-30
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.